Cargando…

The impact of microbial keratitis on quality of life in Uganda

BACKGROUND: Microbial keratitis (MK) is a frequent cause of sight loss in sub-Saharan Africa. However, no studies have formally measured its impact on quality of life (QoL) in this context. METHODS: As part of a nested case–control design for risk factors of MK, we recruited patients presenting with...

Descripción completa

Detalles Bibliográficos
Autores principales: Arunga, Simon, Wiafe, Geoffrey, Habtamu, Esmael, Onyango, John, Gichuhi, Stephen, Leck, Astrid, Macleod, David, Hu, Victor, Burton, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936408/
https://www.ncbi.nlm.nih.gov/pubmed/31909191
http://dx.doi.org/10.1136/bmjophth-2019-000351
_version_ 1783483726909407232
author Arunga, Simon
Wiafe, Geoffrey
Habtamu, Esmael
Onyango, John
Gichuhi, Stephen
Leck, Astrid
Macleod, David
Hu, Victor
Burton, Matthew
author_facet Arunga, Simon
Wiafe, Geoffrey
Habtamu, Esmael
Onyango, John
Gichuhi, Stephen
Leck, Astrid
Macleod, David
Hu, Victor
Burton, Matthew
author_sort Arunga, Simon
collection PubMed
description BACKGROUND: Microbial keratitis (MK) is a frequent cause of sight loss in sub-Saharan Africa. However, no studies have formally measured its impact on quality of life (QoL) in this context. METHODS: As part of a nested case–control design for risk factors of MK, we recruited patients presenting with MK at two eye units in Southern Uganda between December 2016 and March 2018 and unaffected individuals, individually matched for sex, age and location. QoL was measured using WHO Health-Related and Vision-Related QoL tools (at presentation and 3 months after start of treatment in cases). Mean QoL scores for both groups were compared. Factors associated with QoL among the cases were analysed in a linear regression model. RESULTS: 215 case-controls pairs were enrolled. The presentation QoL scores for the cases ranged from 20 to 65 points. The lowest QoL was visual symptom domain; mean 20.7 (95% CI 18.8 to 22.7) and the highest was psychosocial domain; mean 65.6 (95% CI 62.5 to 68.8). At 3 months, QoL scores for the patients ranged from 80 to 90 points while scores for the controls ranged from 90 to 100. The mean QoL scores of the cases were lower than controls across all domains. Determinants of QoL among the cases at 3 months included visual acuity at 3 months and history of eye loss. CONCLUSION: MK severely reduces QoL in the acute phase. With treatment and healing, QoL subsequently improves. Despite this improvement, QoL of someone affected by MK (even with normal vision) remains lower than unaffected controls.
format Online
Article
Text
id pubmed-6936408
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-69364082020-01-06 The impact of microbial keratitis on quality of life in Uganda Arunga, Simon Wiafe, Geoffrey Habtamu, Esmael Onyango, John Gichuhi, Stephen Leck, Astrid Macleod, David Hu, Victor Burton, Matthew BMJ Open Ophthalmol Original Research BACKGROUND: Microbial keratitis (MK) is a frequent cause of sight loss in sub-Saharan Africa. However, no studies have formally measured its impact on quality of life (QoL) in this context. METHODS: As part of a nested case–control design for risk factors of MK, we recruited patients presenting with MK at two eye units in Southern Uganda between December 2016 and March 2018 and unaffected individuals, individually matched for sex, age and location. QoL was measured using WHO Health-Related and Vision-Related QoL tools (at presentation and 3 months after start of treatment in cases). Mean QoL scores for both groups were compared. Factors associated with QoL among the cases were analysed in a linear regression model. RESULTS: 215 case-controls pairs were enrolled. The presentation QoL scores for the cases ranged from 20 to 65 points. The lowest QoL was visual symptom domain; mean 20.7 (95% CI 18.8 to 22.7) and the highest was psychosocial domain; mean 65.6 (95% CI 62.5 to 68.8). At 3 months, QoL scores for the patients ranged from 80 to 90 points while scores for the controls ranged from 90 to 100. The mean QoL scores of the cases were lower than controls across all domains. Determinants of QoL among the cases at 3 months included visual acuity at 3 months and history of eye loss. CONCLUSION: MK severely reduces QoL in the acute phase. With treatment and healing, QoL subsequently improves. Despite this improvement, QoL of someone affected by MK (even with normal vision) remains lower than unaffected controls. BMJ Publishing Group 2019-12-23 /pmc/articles/PMC6936408/ /pubmed/31909191 http://dx.doi.org/10.1136/bmjophth-2019-000351 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Arunga, Simon
Wiafe, Geoffrey
Habtamu, Esmael
Onyango, John
Gichuhi, Stephen
Leck, Astrid
Macleod, David
Hu, Victor
Burton, Matthew
The impact of microbial keratitis on quality of life in Uganda
title The impact of microbial keratitis on quality of life in Uganda
title_full The impact of microbial keratitis on quality of life in Uganda
title_fullStr The impact of microbial keratitis on quality of life in Uganda
title_full_unstemmed The impact of microbial keratitis on quality of life in Uganda
title_short The impact of microbial keratitis on quality of life in Uganda
title_sort impact of microbial keratitis on quality of life in uganda
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936408/
https://www.ncbi.nlm.nih.gov/pubmed/31909191
http://dx.doi.org/10.1136/bmjophth-2019-000351
work_keys_str_mv AT arungasimon theimpactofmicrobialkeratitisonqualityoflifeinuganda
AT wiafegeoffrey theimpactofmicrobialkeratitisonqualityoflifeinuganda
AT habtamuesmael theimpactofmicrobialkeratitisonqualityoflifeinuganda
AT onyangojohn theimpactofmicrobialkeratitisonqualityoflifeinuganda
AT gichuhistephen theimpactofmicrobialkeratitisonqualityoflifeinuganda
AT leckastrid theimpactofmicrobialkeratitisonqualityoflifeinuganda
AT macleoddavid theimpactofmicrobialkeratitisonqualityoflifeinuganda
AT huvictor theimpactofmicrobialkeratitisonqualityoflifeinuganda
AT burtonmatthew theimpactofmicrobialkeratitisonqualityoflifeinuganda
AT arungasimon impactofmicrobialkeratitisonqualityoflifeinuganda
AT wiafegeoffrey impactofmicrobialkeratitisonqualityoflifeinuganda
AT habtamuesmael impactofmicrobialkeratitisonqualityoflifeinuganda
AT onyangojohn impactofmicrobialkeratitisonqualityoflifeinuganda
AT gichuhistephen impactofmicrobialkeratitisonqualityoflifeinuganda
AT leckastrid impactofmicrobialkeratitisonqualityoflifeinuganda
AT macleoddavid impactofmicrobialkeratitisonqualityoflifeinuganda
AT huvictor impactofmicrobialkeratitisonqualityoflifeinuganda
AT burtonmatthew impactofmicrobialkeratitisonqualityoflifeinuganda